NCT02139215View on ClinicalTrials.gov

Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Colorectal Cancer Metastatic
Trial Locations (5)

G6V 3Z1

CSSS Alphonse-Desjardins (CHAU, Hôtel-Dieu de Lévis), Lévis

H1T 2M4

CIUSSS de l'Est-de-l'Île-de-Montréal (Hôpital Maisonneuve-Rosemont), Montreal

H2X 3J4

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke

G1R 2J6

Centre Hospitalier Universitaire de Québec (CHU, Hôtel-Dieu de Québec), Québec

Sponsors

Lead Sponsor

PeriPharm
All Listed Sponsors
collaborator

Personalized Medicine Partnership for Cancer

OTHER

lead

PeriPharm

OTHER

NCT02139215 - Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter